Article
Saccharomyces cerevisiae as a platform for assessing sphingolipid lipid kinase inhibitors.
PloS one - 1 Jan 2018
Kharel Yugesh, Agah Sayeh, Huang Tao, Mendelson Anna J, Eletu Oluwafunmilayo T, Barkey-Bircann Peter, Gesualdi James, Smith Jeffrey S, Santos Webster L, Lynch Kevin R
Abstract excerpt
Successful medicinal chemistry campaigns to discover and optimize sphingosine kinase inhibitors require a robust assay for screening chemical libraries and for determining rank order potencies. Existing assays for these enzymes are laborious, expensive and/or low throughput. The toxicity of excessive levels of phosphorylated sphingoid bases for the budding yeast, Saccharomyces cerevisiae, affords an assay wherein...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
